Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis

Small cell lung cancer (SCLC) is the most aggressive type of lung cancer due to a fast tumor doubling time and early hematogenous spread. Advances in the treatment of non-small cell lung cancer using targeted therapies having been made, but no targeted drugs for SCLC have been approved. The Wnt sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wenxuan, Shen, Fangzhen, Xiao, Wenjing, Chen, Jing, Pan, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754901/
https://www.ncbi.nlm.nih.gov/pubmed/29344117
http://dx.doi.org/10.3892/ol.2017.7100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754901/
https://www.ncbi.nlm.nih.gov/pubmed/29344117
http://dx.doi.org/10.3892/ol.2017.7100

Ejemplares similares